1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Consent for publication: why it matters now more than ever. (1st December 2020) Authors: Ahmed, S.; Shipman, A.; Millington, G.; A. Langan, E.; R. Ingram, J. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 8(2020) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Consent for publication: why it matters now more than ever. (1st September 2020) Authors: Ahmed, S.; Shipman, A.; Millington, G.; Langan, E. A.; Ingram, J. R. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Consent for publication: why it matters now more than ever. (2nd September 2020) Authors: Ahmed, S.; Shipman, A.; Millington, G.; Langan, E. A.; Ingram, J. R. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Consent for publication: why it matters now more than ever. (2nd September 2020) Authors: Ahmed, S.; Shipman, A.; Millington, G.; A. Langan, E.; R. Ingram, J. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 8(2020) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Consent for publication: Why it matters now more than ever?. Issue 1 (2nd September 2020) Authors: Ahmed, S.; Shipman, A.R.; Millington, G.; Langan, E.A.; Ingram, J.R. Journal: Skin health and disease Issue: Volume 1:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The first purely open access dermatology journal from the British Association of Dermatologists and Wiley. Issue 1 (7th August 2020) Authors: Millington, G. Journal: Skin health and disease Issue: Volume 1:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗